Login to your account
Don’t have an account?
Create a Free Account
Editor's Choice
A randomized, non-inferiority trial on the DuoStim strategy in PGT-A cycles
Is the DuoStim strategy an effective alternative to two conventional ovarian stimulation cycles in poor-prognosis patients undergoing preimplantation genetic testing for aneuploidies (PGT-A) to improve euploidy rates and obtain the first euploid embryo in less time?Concordance of PGT for aneuploidies between blastocyst biopsies and spent blastocyst culture medium
Non-invasive preimplantation genetic testing for aneuploidies (niPGT-A) avoids the possible detrimental impact of invasive PGT-A on embryo development and clinical outcomes. Does cell-free DNA (cfDNA) from spent blastocyst culture medium (BCM) reflect embryonic chromosome status better than trophectoderm (TE) biopsy?Preimplantation genetic testing for human blastocysts with potential parental contamination using a quantitative parental contamination test (qPCT): an evidence-based study
Is it possible to develop a quantitative method for detecting parental DNA contamination in conventional IVF using preimplantation genetic testing for aneuploidy (PGT-A)?Ovulation induction using sequential letrozole/gonadotrophin in infertile women with PCOS: a randomized controlled trial
Polycystic ovary syndrome (PCOS) is the most common ovarian endocrine disease in women of reproductive age (Conway et al., 2014), with an incidence among premenopausal women of up to 20% when applying Rotterdam criteria (Yildiz et al., 2012). Oligo-ovulation is the most important and classic clinical manifestation of PCOS (Escobar-Morreale, 2018), and the resulting infertility is the major cause of anovulatory infertility (Balen and Michelmore, 2002), which affects many infertile women of reproductive age.
